• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Johns Hopkins

8 drug delivery innovations you need to know

February 25, 2021 By Sean Whooley Leave a Comment

The drug delivery space has seen plenty of innovation over the years and there are no signs of that slowing down any time soon. Improvements upon established technologies like insulin delivery devices and inhalers have been presented by some, while others have unlocked new ways of delivering drugs through a variety of means. Among the […]

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations, Featured, Pharmaceutical Tagged With: dyvebioscience, Enable Injections, evoxtherapeutics, Inovio Pharmaceuticals, Johns Hopkins, Lyra Therapeutics, Medtronic, Tandem Diabetes Care, Teva Pharmaceuticals, Teva Respiratory

Abbott: ID NOW COVID-19 results more accurate with earlier testing

May 21, 2020 By Nancy Crotti

Abbott (NYSE:ABT) said today that its ID NOW COVID-19 test works better on specimens collected soon after patients begin showing symptoms. The test’s performance has drawn fire from federal officials in recent weeks, including a recent FDA warning that the ID NOW test may return false-negative results. The agency granted the test an emergency use authorization […]

Filed Under: Business/Financial News, Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Research & Development, Wall Street Beat Tagged With: Abbott, coronavirus, COVID-19, Everett Clinic, FDA, Johns Hopkins, Roche, U.S. Centers for Disease Control and Prevention

Nanoparticles use 2 mechanisms to boost immunotherapy

June 12, 2017 By Sarah Faulkner

Cancer immunotherapy, a treatment approach that has gained momentum over the past few years, only helps a small fraction of patients. But researchers from the Johns Hopkins University School of Medicine have developed a nanoparticle that may one day help expand the patient population that benefits from immunotherapy. Immunotherapy usually falls into 1 of 2 […]

Filed Under: Oncology, Research & Development Tagged With: Johns Hopkins

Nanoparticles permeate lungs to deliver pulmonary drugs

April 11, 2017 By Sarah Faulkner

Researchers from Johns Hopkins University have developed nanoparticles that can shuttle chemicals through the thick mucus membranes of pulmonary airways to deliver drugs. The team’s work was published in the journal Science Advances.  Traditional therapies for cystic fibrosis, COPD and asthma include inhaled corticosteroids that adhere to the walls of air passages. Thick mucus tends to build […]

Filed Under: Pharmaceutical, Research & Development, Respiratory Tagged With: Johns Hopkins

BioCardia, Johns Hopkins treats first patient with CardiAmp cell therapy in Phase III trial

February 28, 2017 By Sarah Faulkner

Johns Hopkins, the Maryland Stem Cell Research Fund and BioCardia (NSDQ:BCDA) said today that the 1st patient has been treated in a pivotal Phase III trial of the CardiAmp cell-based therapy for the treatment of ischemic heart failure. The investigational therapy was designed to deliver a dose of a patient’s own bone marrow cells directly […]

Filed Under: Cardiovascular, Clinical Trials, Drug-Device Combinations, Regenerative Medicine, Wall Street Beat Tagged With: BioCardia, Johns Hopkins

Nanofibers prevent infection on prosthetic joints

October 25, 2016 By Sarah Faulkner

Researchers from Johns Hopkins University developed a coating made from antibiotic-releasing nanofibers to prevent bacterial infections related to total joint replacement surgery. The work was published this week in Proceedings of the National Academy of Science. Although the team used rodents’ knee joints to demonstrate the effects of the nanofiber film, they suggest that the coating […]

Filed Under: Orthopedics, Prosthetics, Research & Development Tagged With: Johns Hopkins

Light-based arrhythmia treatment skips the shocks

September 14, 2016 By Sarah Faulkner

Researchers at Johns Hopkins University and Germany’s University of Bonn showed that light can restore a normal heartbeat and replace electric shocks in patients at risk for arrhythmia, according to a press release from the Baltimore school. The work was published online yesterday in the Journal of Clinical Investigations and could 1 day be used […]

Filed Under: Cardiovascular, Research & Development Tagged With: Cardiac Rhythm Management, Johns Hopkins, University of Bonn

Johns Hopkins launches epilepsy study using Apple Watch

October 16, 2015 By Fink Densford

Johns Hopkins University said yesterday it is launching the EpiWatch patient data collection app for Apple‘s (NSDQ:AAPL) Apple Watch to collect data for patients with epilepsy before, during and after seizures. Data from the app will be used to analyze and better understand epilepsy, and to develop new methods for monitoring and managing the disease, […]

Filed Under: Digital Health, Patient Monitoring, Research & Development, Software / IT Tagged With: Apple, Johns Hopkins

Docs announce lab-made ‘mini retina’

June 11, 2014 By Arezu Sarvestani Leave a Comment

Docs announce lab-made 'mini retina'

Johns Hopkins researchers reported what may be a major breakthrough in vision-saving medicine, creating a functioning "mini retina" made out of human stem cells.

Filed Under: News Well, Optical/Ophthalmic, Regenerative Medicine, Research & Development, Stem Cells Tagged With: Johns Hopkins

Bakris: Symplicity-3 a prologue for renal denervation | MassDevice.com On Call

April 22, 2014 By MassDevice Leave a Comment

MassDevice.com On Call

MASSDEVICE ON CALL — Dr. George Bakris, the co-principal investigator for Medtronic‘s (NYSE:MDT) failed Symplicty-3 renal denervation trial, believes further clinical work should be tabled until a few key questions about the therapy are answered.

Filed Under: Digital Health, News Well, Urology Tagged With: American College of Cardiology, Hypertension, Johns Hopkins, National Institutes of Health (NIH), Olympus

GPOs: Premier, John Hopkins Health System expand relationship

December 9, 2013 By Chris Walker Leave a Comment

GPO:Premier, John Hopkins Health System expand relationship

John Hopkins Health System said it is expanding its relationship with group purchasing organization Premier Inc. (NSDQ:PINC), to include all 6 hospitals within its network.

Filed Under: News Well Tagged With: Deals Roundup, Group Purchasing Organizations (GPO), Johns Hopkins, Premier Inc.

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS